Hoobrah a Telehealth Company for Diabetic Patients
By: Dominic N. Velasco, MD
I. BUSINESS CONCEPT
Hoobrah is a telehealth concept that gives consultations to patients diagnosed with insulin dependent or non-insulin dependent diabetes mellitus 24/7. A smartphone app is the line of communication between patient and healthcare provider. Patients can use a messenger app embedded in the software or interact via video call directly to the health care professional through voice over internet protocol which is also available on the app. They can also log in their blood test results and daily blood sugar monitoring for assessment. A healthcare professional - nurse, diabetologist or endocrinologist will be by their side 24/7.
Hoobrah is also an online pharmaceutical retailer of important hypoglycemic agents that is necessary for these patients. It will ensure cost effective and readily accessible anti-diabetes drugs to its customers.
<rationale for choosing this: passion, economic engine or competency>
II. BUSINESS MODEL
- EXECUTIVE SUMMARY
- VMOKRAPI
Vision: In 2022, grow Hoobrah into a leading telemedicine service provider and retailer of hypoglycemic agents for diabetic patients in Central Luzon with an annual sales of P60,000,000.
Mission: Hoobra will provide diabetic patients in the Philippines accessible and affordable telehealth care via advanced electronic communications and telecommunication technologies and medicines as a means to provide profit to its business partners.
Objectives
- To be the Philippines' leading telemedicine service provider for diabetic patients.
- To provide diabetic patients accessible, and cost effective diabetic care.
- To deliver affordable hypoglycemic agents to patients.
- To have happy customers and realize the value of Telemedicine with high quality medical consultations.
- To make a profit for its owners.
- To make Hoobrah's employees feel that Hoobrah is the best company to work for.
Key Result Areas / Performance Indicators
KRA
|
PI
| ||
2017
|
2018
|
2022
| |
1.a. Number of diabetic patients users nationwide.
|
10,824
|
12,989
|
18,714
|
1.b. Sales volume of medical consultations.
|
P19,899,792
|
P26,267,625
|
P59,876,460
|
1.d. Market share Nationwide.
|
0.10%
|
0.12%
|
0.18%
|
2.a. Survey ratings from customers.
|
2.5/5.0
|
3.5/5.0
|
4.0/5.0
|
2.b. Percentage of repeat customers.
|
35%
|
50%
|
65%
|
2.c. Percentage of controlled diabetes mellitus patients.
|
60%
|
80%
|
99%
|
2.d. Percentage of customer morbidity secondary to diabetes mellitus after availing of service.
|
19%
|
15%
|
10%
|
2.e. Percentage of mortality secondary to diabetes mellitus after availing of service.
|
25%
|
22%
|
15%
|
3.a. Amount of net profits for the next 5 years.
|
(P85,208)
|
P3,638,487
|
P23,420,928
|
3.b. Payback Period
|
3.21 years
| ||
3.c. Return on equity.
|
(1.42%)
|
60.6%
|
390%
|
3.d. Return on Investment.
|
(0.47%)
|
18.6%
|
88.7%
|
4.a. Employee turnover rate.
|
5 out of 20 per year
|
4 out of 20 per year
|
1 out of 20 per year
|
4.b. Compensation and benefits are above par.
|
5% above industry standard
|
8% above industry standard
|
15% above industry Standard
|
4.c. Number of job applicants.
|
10% more job applicants
|
20% more job applicants
|
30% more job applicants
|
